Risk of severe abnormal uterine bleeding associated with rivaroxaban compared with apixaban, dabigatran and warfarin

E Eworuke, L Hou, R Zhang, HL Wong, P Waldron… - Drug Safety, 2021 - Springer
Introduction There have been reports of clinically relevant uterine bleeding events among
women of reproductive age exposed to rivaroxaban. Objective The aim of this study was to …
被引用次数：11 相关文章

Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin

E Eworuke, L Hou, R Zhang, HL Wong… - Drug …, 2021 - search.proquest.com
Introduction There have been reports of clinically relevant uterine bleeding events among
women of reproductive age exposed to rivaroxaban. Objective The aim of this study was to …

Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin

E Eworuke, L Hou, R Zhang, HL Wong… - Drug …, 2021 - econpapers.repec.org
Introduction There have been reports of clinically relevant uterine bleeding events among
women of reproductive age exposed to rivaroxaban. Objective The aim of this study was to …

Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin.

E Eworuke, L Hou, R Zhang, HL Wong, P Waldron… - Drug Safety, 2021 - europepmc.org
Objective The aim of this study was to compare the risk of severe abnormal uterine bleeding
(SAUB) resulting in transfusion or surgical intervention among women on rivaroxaban …

Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin

E Eworuke, L Hou, R Zhang, HL Wong… - Drug …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction There have been reports of clinically relevant uterine bleeding events among
women of reproductive age exposed to rivaroxaban. Objective The aim of this study was to …

Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin

E Eworuke, L Hou, R Zhang, HL Wong, P Waldron… - Drug Safety, 2021 - ideas.repec.org
Introduction There have been reports of clinically relevant uterine bleeding events among
women of reproductive age exposed to rivaroxaban. Objective The aim of this study was to …